Press release
Sustained Release Excipients Market Size, Trends & Outlook 2024-2033
The Business Research Company recently released a comprehensive report on the Global Sustained Release Excipients Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.According to The Business Research Company's, The sustained release excipients market size has grown strongly in recent years. It will grow from $1.29 billion in 2023 to $1.41 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increased demand for controlled drug release, chronic disease prevalence, patient compliance and convenience, pharmaceutical industry innovations, regulatory support for extended-release formulations..
The sustained release excipients market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing geriatric population, focus on personalized medicine, challenges in patient adherence, rise in complex drug formulations, advancements in disease management, global healthcare expansion.. Major trends in the forecast period include patient-centric drug delivery, collaborations for formulation development, regulatory compliance and safety, global expansion of drug formulation technologies, influence of biopharmaceuticals..
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report
Market Drivers and Trends:
The increasing prevalence of chronic and acute diseases is expected to propel the growth of the sustained-release excipients market going forward. Chronic and acute diseases are two distinct categories used to classify different illnesses based on their duration and progression. Chronic diseases are long-lasting medical conditions that persist over an extended period, typically three months or more. Acute diseases are characterized by a rapid onset of symptoms that are usually severe but short-lived. These diseases develop suddenly and generally last briefly, ranging from hours to days or weeks. Sustained-release excipients are widely used to formulate pharmaceutical products for both chronic and acute diseases. It improves patient adherence, maintains consistent drug levels, reduces side effects, and improves disease management, so these factors boost the sales of sustained-release excipients. For instance, in September 2022, according to the World Health Organization (WHO), a Switzerland-based specialized health agency, cardiovascular diseases accounted for most NCD deaths, or 17.9 million people annually, followed by chronic respiratory illnesses (4.1 million), diabetes (2.0 million, including fatalities from renal disease brought on by diabetes), and cancer (9.3 million). Furthermore, in October 2022, according to an article published by the Pan American Health Organization, a US-based international public health agency, approximately 10.6 million people fell ill with tuberculosis (TB) in 2021, an increase of 4.5% from 2020. Therefore, the increasing prevalence of chronic and acute diseases drives the growth of the sustained-release excipients market.
Product innovation is the key trend gaining popularity in the sustained release excipients market. Major companies operating in the sustained release excipients market are developing innovative products to strengthen their position in the market. For instance, in September 2022, Nutriventia Limited, an India-based pharmaceutical company, launched Prolanza, a sustained-release ashwagandha ingredient (Withania somnifera). It is an advanced Ashwagandha root-only extract that offers continuous stress-reduction support. Prolanza's unique release mechanism allows it to exhibit its therapeutic effects over an extended period with just one dose each day. IProlanza ashwagandha demonstrated better relative absorption, improved bioavailability, and a longer elimination half-life when compared to the control component, indicating a sustained-release profile. Prolanza's therapeutic effects will last longer and have a higher overall good influence on health because ashwagandha is primarily used for its capacity to adapt and lessen stress responses. It's manufactured from natural herbs and has been clinically confirmed to work.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp
Major Key Players of the Market:
Mylan N.V.; Pfizer Inc.; Sun Pharmaceutical Industries Ltd.; Novartis AG; Ashland Global Holdings; Salix Pharmaceuticals; Allergan PLC; AstraZeneca; GlaxoSmithKline PLC; Mayne Pharma Group Limited; BASF Aktiengesellschaft; International Flavors & Fragrances Inc.; Croda International Plc; Gattefossé SAS; Merck KGaA; Food Machinery and Chemical Corporation; Roquette Freres; Colorcon Inc; Dow Chemical Company; Wacker Chemie AG; Evonik Industries Inc.; Lubrizol Corporation; Shin-Etsu Chemical Co. Ltd.; Eastman Chemical Company; Kerry Group plc; Innophos Holdings Inc.; Sensient Technologies Corporation; Koninklijke DSM N.V.; Ingredion Incorporated; Cargill Incorporated; Archer Daniels Midland Company; DuPont de Nemours Inc.; Lonza Group
Sustained Release Excipients Market 2024 Key Insights:
• The sustained release excipients market will grow to $1.96 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%.
• Rising Prevalence Of Chronic And Acute Diseases Fuels Growth In The Sustained-Release Excipients Market
• Sustained Release Excipients Market Advances With Product Innovation
• North America was the largest region in the global sustained release excipients market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10822&type=smp
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sustained Release Excipients Market Size, Trends & Outlook 2024-2033 here
News-ID: 3753893 • Views: …
More Releases from The Business research company
Leading Companies Fueling Growth and Innovation in the Sun Care Products Market
The sun care products market is on track for substantial expansion as consumer awareness about skin protection intensifies worldwide. With evolving preferences and technological advancements shaping product offerings, this sector is set to witness robust growth in the coming years. Let's explore the market's size projections, key players, emerging trends, and major segments driving its development through 2030.
Projected Size and Growth Trajectory of the Sun Care Products Market
The…
Future Perspectives: Key Trends Shaping the Styrene Butadiene Rubber (SBR) Based …
The styrene butadiene rubber (SBR) based adhesive market is on track for notable growth as we approach 2030. Driven by a variety of factors including expanding infrastructure projects and rising demand across multiple industries, this sector is poised for steady expansion. Let's explore the market's size projections, key players, emerging trends, and the main segments shaping its future.
Projected Growth and Market Size of Styrene Butadiene Rubber Based Adhesives
The…
Emerging Sub-Segments Transforming the Stearic Acid Market Landscape
The stearic acid market is poised for significant expansion in the coming years, driven by evolving demand across various industries. This report explores the projected market size, leading companies, key trends, and segment analysis shaping the future of this vital chemical.
Stearic Acid Market Size and Growth Outlook
The stearic acid market is set to grow robustly, reaching a valuation of $54.63 billion by 2030. This represents a compound annual…
Market Trend Insights: The Impact of Recent Innovations on the Specialty Pestici …
The specialty pesticides sector is on the verge of significant expansion as global agricultural practices continue to evolve. Driven by increasing demand for crop protection and sustainable farming techniques, this market is set to experience robust growth in the coming years. Let's explore the market's anticipated value, leading companies, emerging trends, and detailed segmentation to gain a comprehensive understanding of this dynamic industry.
Projected Market Size and Growth Expectations for Specialty…
More Releases for Sustained
Best crypto presale data reflects Pepenode sustained inflows
Early crypto presale data points to Pepenode's Pepeto presale as one of the more notable opportunities in meme coin presale 2026. Reported entry pricing at $0.000000178 and presale fundraising that has surpassed $7.17 million show strong presale inflows and early investor demand.
On-chain metrics reveal accumulation by larger addresses and capital rotation from legacy meme tokens into $PEPETO allocations. Wallet behavior and supply mechanics-capped at 420 trillion tokens-mirror prior meme models…
Best crypto presale data reflects Pepenode sustained inflows
Pepenode presale activity offers a clear case study in presale fundraising velocity and on-chain proof. Press reporting from CryptoTimes24 (January 2, 2026) cites combined raises between $2.12 million and $2.3 million, driven by laddered sales and tiered pricing that sped stage fills. These mechanics pushed rapid deposits and created measurable presale KPIs for short-term momentum.
On-chain explorers such as Etherscan and BscScan logged large token timelocks and multi-month vesting schedules. Public…
Best crypto presale data reflects Pepenode sustained inflows
Late-2025 coverage from CryptoTimes24 marks a clear shift: the best crypto presale decisions now lean on hard metrics. Audits from CertiK, Trail of Bits, and Coinsult, verified liquidity locks, and structured vesting schedules have moved to the forefront of due diligence. That change reshaped how traders read presale inflows and evaluate meme coin presale opportunities.
Pepenode's (https://pepenode.io/) presale drew sustained interest that checks many of these boxes. On-chain records show laddered…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Electroceramics Market: Pioneering Innovations and Sustained Growth
Based on the analysis by Fact.MR, the global electroceramics market is valued to be US$ 10.1 billion in 2023 and it is expected to grow at a CAGR of 4.0% to reach US$ 15.0 billion by the end of 2033.
The global electroceramics market is a dynamic and rapidly evolving sector that plays a pivotal role in modern technology-driven industries. These advanced ceramic materials are engineered to exhibit unique electrical, magnetic,…
Global Sustained Release Excipients Market Size & Trends
According to a new market research report published by Global Market Estimates, the global sustained release excipients market is projected to grow at a CAGR of 8.6% from 2023 to 2028.
The primary factors driving the market growth include growing demand for extended-release drug formulations, increasing prevalence of chronic diseases requiring long-term medication, advancements in drug delivery technologies, the need for reduced dosing frequency, and the rising focus on personalized medicine…
